In reversal of recent developments, officials in Thailand have signaled that cannabis will not be re-criminalized.
On Tuesday, July 23, 2024, Thailand’s Deputy Prime Minister and Minister of Interior, Anutin Charnvirakul announced that cannabis would not be re-labeled a narcotic, as had been proposed earlier this year by Prime Minister Srettha Thavisin, who was elected in 2023 (1,2). As a narcotic, growing, possessing, and consuming cannabis would have become illegal (T). Anutin, who had previously served as the Minister of Public Health, also stated that plans for the government to regulate the country’s cannabis industry were being discussed. “I thank the Prime Minister for considering this and deciding on legislation,” added Anutin, who has voiced his opposition to cannabis as a narcotic (3).
Under previous leadership, cannabis became legal for medical purposes in 2018 and decriminalized in 2022, making Thailand the first country in Asia to do so (4). As a result, the country’s businesses and tourism grew significantly, though regulations of the industry were virtually nonexistent and resulted in disagreements between governing parties (3). Thousands of new dispensaries opened, and the industry is predicted to be worth $1.2 billion by next year (1). The plant had also been originally promoted as a cash crop to support farmers.
In 2023, Srettha announced his intent to limit cannabis to medical use only, citing concerns of widespread and uncontrolled usage that posed a danger to youths (5). A draft of the new restrictions was released in March 2024, and this draft still stands, stated Public Health Minister Somsak Thepsuthin (3). "It will be a matter of law and debated in parliament where there is already a draft law," stated Prommin Lertsuridej, secretary-general to the prime minister (1). "Whether it is a narcotic or not is up to parliament." If approved, the draft would criminalize cannabis starting in 2025 (3).
Earlier this month, nearly one hundred activists gathered in Bangkok to protest the possible ban on the plant, and had remained at the Government House for a week (6,3). “This fight for cannabis is not only for medical security or people’s rights but also for destroying the monopoly of politicians taking (its) benefits away from the people,” stated advocate Prasitchai Nunuan at the protest (6).
References
Cannabis, US Presidential Election 2024, and Beyond: A Roundtable Discussion, Part II
December 17th 2024With the recent 2024 presidential election behind us, the future of cannabis still has many unknowns moving forward and questions still to be discussed. In this roundtable discussion with four knowledgeable industry leaders, we explore the nuanced political landscape of cannabis legalization and rescheduling in the context of the election, including state and federal policies and possible paths forward for testing standardization. Join us in the second part of a compilation of responses from Kim Anzarut, CQA, CP-FS, CEO of Allay Consulting; Susan Audino, PhD, founder of S.A. Audino & Associates, LLC; Zacariah Hildenbrand, PhD, research Professor at the University of Texas at El Paso; and David Vaillencourt, CEO of The GMP Collective.
Cannabis, US Presidential Election 2024, and Beyond: A Roundtable Discussion, Part I
December 16th 2024With the recent 2024 presidential election behind us, the future of cannabis still has many unknowns moving forward and questions still to be discussed. In this roundtable discussion with four knowledgeable industry leaders, we explore the nuanced political landscape of cannabis legalization and rescheduling in the context of the election. We discuss what drives support or opposition from both sides of the aisle, the complexities of balancing state and federal priorities, and more. Join us in the first part of a compilation of responses from Kim Anzarut, CQA, CP-FS, CEO of Allay Consulting; Susan Audino, PhD, founder of S.A. Audino & Associates, LLC; Zacariah Hildenbrand, PhD, research Professor at the University of Texas at El Paso; and David Vaillencourt, CEO of The GMP Collective.
Work Smarter, Not Harder: How ASTM Standards for Cannabinoids Improve Your Operations
December 3rd 2024ASTM Standards D8557-24 and D8556-24, provide unified guidelines for GMP (Good Manufacturing Practices) and QMS (Quality Management Systems) in cannabis operations. These standards enhance compliance, product safety, and operational consistency across the industry for the benefit of operators, consumers, and other stakeholders in the industry.